KONINKLIJKE PHILIPS NVR- NY (PHG) Stock Fundamental Analysis

NYSE:PHG • US5004723038

31.48 USD
+0.26 (+0.83%)
At close: Feb 18, 2026
31.6 USD
+0.12 (+0.38%)
After Hours: 2/18/2026, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PHG. PHG was compared to 185 industry peers in the Health Care Equipment & Supplies industry. While PHG is still in line with the averages on profitability rating, there are concerns on its financial health. PHG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • PHG had positive earnings in the past year.
  • PHG had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: PHG reported negative net income in multiple years.
  • Of the past 5 years PHG 4 years had a positive operating cash flow.
PHG Yearly Net Income VS EBIT VS OCF VS FCFPHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

1.2 Ratios

  • The Return On Assets of PHG (3.32%) is better than 79.46% of its industry peers.
  • PHG's Return On Equity of 8.17% is amongst the best of the industry. PHG outperforms 82.16% of its industry peers.
  • PHG has a Return On Invested Capital of 5.79%. This is in the better half of the industry: PHG outperforms 77.84% of its industry peers.
  • PHG had an Average Return On Invested Capital over the past 3 years of 3.64%. This is significantly below the industry average of 8.75%.
  • The 3 year average ROIC (3.64%) for PHG is below the current ROIC(5.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROIC 5.79%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.64%
ROIC(5y)N/A
PHG Yearly ROA, ROE, ROICPHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • PHG has a better Profit Margin (5.02%) than 77.30% of its industry peers.
  • In the last couple of years the Profit Margin of PHG has declined.
  • PHG has a better Operating Margin (7.98%) than 74.59% of its industry peers.
  • In the last couple of years the Operating Margin of PHG has declined.
  • PHG has a Gross Margin of 45.18%. This is in the lower half of the industry: PHG underperforms 61.08% of its industry peers.
  • In the last couple of years the Gross Margin of PHG has remained more or less at the same level.
Industry RankSector Rank
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
OM growth 3YN/A
OM growth 5Y-5.59%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
PHG Yearly Profit, Operating, Gross MarginsPHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHG is destroying value.
  • The number of shares outstanding for PHG has been increased compared to 1 year ago.
  • Compared to 5 years ago, PHG has more shares outstanding
  • PHG has a worse debt/assets ratio than last year.
PHG Yearly Shares OutstandingPHG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
PHG Yearly Total Debt VS Total AssetsPHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • PHG has a debt to FCF ratio of 16.37. This is a negative value and a sign of low solvency as PHG would need 16.37 years to pay back of all of its debts.
  • PHG's Debt to FCF ratio of 16.37 is fine compared to the rest of the industry. PHG outperforms 70.81% of its industry peers.
  • A Debt/Equity ratio of 0.63 indicates that PHG is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.63, PHG is not doing good in the industry: 64.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Altman-Z N/A
ROIC/WACC0.87
WACC6.64%
PHG Yearly LT Debt VS Equity VS FCFPHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.32 indicates that PHG should not have too much problems paying its short term obligations.
  • The Current ratio of PHG (1.32) is worse than 78.38% of its industry peers.
  • A Quick Ratio of 0.94 indicates that PHG may have some problems paying its short term obligations.
  • PHG has a Quick ratio of 0.94. This is in the lower half of the industry: PHG underperforms 79.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.94
PHG Yearly Current Assets VS Current LiabilitesPHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

4

3. Growth

3.1 Past

  • PHG shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.11%.
  • Measured over the past years, PHG shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.62% on average per year.
  • Looking at the last year, PHG shows a decrease in Revenue. The Revenue has decreased by -1.04% in the last year.
  • PHG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.59% yearly.
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%

3.2 Future

  • PHG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.42% yearly.
  • The Revenue is expected to grow by 3.77% on average over the next years.
EPS Next Y3.51%
EPS Next 2Y8.11%
EPS Next 3Y15.73%
EPS Next 5Y8.42%
Revenue Next Year1.71%
Revenue Next 2Y3.03%
Revenue Next 3Y3.53%
Revenue Next 5Y3.77%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHG Yearly Revenue VS EstimatesPHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHG Yearly EPS VS EstimatesPHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

  • PHG is valuated rather expensively with a Price/Earnings ratio of 18.09.
  • Compared to the rest of the industry, the Price/Earnings ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 84.86% of the companies listed in the same industry.
  • PHG is valuated rather cheaply when we compare the Price/Earnings ratio to 27.27, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 17.49 indicates a rather expensive valuation of PHG.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 84.86% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of PHG to the average of the S&P500 Index (28.16), we can say PHG is valued slightly cheaper.
Industry RankSector Rank
PE 18.09
Fwd PE 17.49
PHG Price Earnings VS Forward Price EarningsPHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PHG is valued cheaper than 86.49% of the companies in the same industry.
  • 74.05% of the companies in the same industry are more expensive than PHG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 51.89
EV/EBITDA 12.05
PHG Per share dataPHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • PHG's earnings are expected to grow with 15.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.15
PEG (5Y)N/A
EPS Next 2Y8.11%
EPS Next 3Y15.73%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.84%, PHG has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.20, PHG pays a better dividend. On top of this PHG pays more dividend than 98.92% of the companies listed in the same industry.
  • PHG's Dividend Yield is rather good when compared to the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 3.84%

5.2 History

  • On average, the dividend of PHG grows each year by 216.55%, which is quite nice.
  • PHG has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)216.55%
Div Incr Years0
Div Non Decr Years0
PHG Yearly Dividends per sharePHG Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2025 2026 0.5 1 1.5

5.3 Sustainability

  • PHG pays out 36.65% of its income as dividend. This is a sustainable payout ratio.
  • PHG's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP36.65%
EPS Next 2Y8.11%
EPS Next 3Y15.73%
PHG Yearly Income VS Free CF VS DividendPHG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B 4B
PHG Dividend Payout.PHG Dividend Payout, showing the Payout Ratio.PHG Dividend Payout.PayoutRetained Earnings

KONINKLIJKE PHILIPS NVR- NY

NYSE:PHG (2/18/2026, 7:00:00 PM)

After market: 31.6 +0.12 (+0.38%)

31.48

+0.26 (+0.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners44.83%
Inst Owner Change-0.37%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap30.31B
Revenue(TTM)17.83B
Net Income(TTM)895.00M
Analysts73.33
Price Target32.34 (2.73%)
Short Float %0.22%
Short Ratio1.93
Dividend
Industry RankSector Rank
Dividend Yield 3.84%
Yearly Dividend0.41
Dividend Growth(5Y)216.55%
DP36.65%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.02%
Min EPS beat(2)3.95%
Max EPS beat(2)14.1%
EPS beat(4)4
Avg EPS beat(4)17.83%
Min EPS beat(4)3.95%
Max EPS beat(4)31.04%
EPS beat(8)4
Avg EPS beat(8)2.84%
EPS beat(12)6
Avg EPS beat(12)6.47%
EPS beat(16)7
Avg EPS beat(16)6.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-0.86%
Revenue beat(4)0
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)-0.86%
Revenue beat(8)0
Avg Revenue beat(8)-2.61%
Revenue beat(12)1
Avg Revenue beat(12)-2.36%
Revenue beat(16)2
Avg Revenue beat(16)-1.72%
PT rev (1m)0.45%
PT rev (3m)1.81%
EPS NQ rev (1m)-15.5%
EPS NQ rev (3m)-15.5%
EPS NY rev (1m)-0.33%
EPS NY rev (3m)-0.56%
Revenue NQ rev (1m)3.12%
Revenue NQ rev (3m)3.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE 18.09
Fwd PE 17.49
P/S 1.44
P/FCF 51.89
P/OCF 22.06
P/B 2.34
P/tB N/A
EV/EBITDA 12.05
EPS(TTM)1.74
EY5.53%
EPS(NY)1.8
Fwd EY5.72%
FCF(TTM)0.61
FCFY1.93%
OCF(TTM)1.43
OCFY4.53%
SpS21.9
BVpS13.46
TBVpS-1.08
PEG (NY)5.15
PEG (5Y)N/A
Graham Number22.95
Profitability
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROCE 7.33%
ROIC 5.79%
ROICexc 6.76%
ROICexgc 23.43%
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
FCFM 2.77%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.64%
ROIC(5y)N/A
ROICexc(3y)4.17%
ROICexc(5y)N/A
ROICexgc(3y)14.41%
ROICexgc(5y)N/A
ROCE(3y)4.62%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1.31%
ROICexc growth 3YN/A
ROICexc growth 5Y-4.82%
OM growth 3YN/A
OM growth 5Y-5.59%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Debt/EBITDA 2.72
Cap/Depr 59.38%
Cap/Sales 3.75%
Interest Coverage 5.63
Cash Conversion 45.59%
Profit Quality 55.2%
Current Ratio 1.32
Quick Ratio 0.94
Altman-Z N/A
F-Score7
WACC6.64%
ROIC/WACC0.87
Cap/Depr(3y)53.03%
Cap/Depr(5y)53.41%
Cap/Sales(3y)3.68%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
EPS Next Y3.51%
EPS Next 2Y8.11%
EPS Next 3Y15.73%
EPS Next 5Y8.42%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%
Revenue Next Year1.71%
Revenue Next 2Y3.03%
Revenue Next 3Y3.53%
Revenue Next 5Y3.77%
EBIT growth 1Y15922.2%
EBIT growth 3YN/A
EBIT growth 5Y-5.03%
EBIT Next Year63.55%
EBIT Next 3YN/A
EBIT Next 5Y17.05%
FCF growth 1Y-43.86%
FCF growth 3YN/A
FCF growth 5Y-22.31%
OCF growth 1Y-25.32%
OCF growth 3YN/A
OCF growth 5Y-15.14%

KONINKLIJKE PHILIPS NVR- NY / PHG FAQ

What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PHG.


Can you provide the valuation status for KONINKLIJKE PHILIPS NVR- NY?

ChartMill assigns a valuation rating of 5 / 10 to KONINKLIJKE PHILIPS NVR- NY (PHG). This can be considered as Fairly Valued.


How profitable is KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

KONINKLIJKE PHILIPS NVR- NY (PHG) has a profitability rating of 5 / 10.


How financially healthy is KONINKLIJKE PHILIPS NVR- NY?

The financial health rating of KONINKLIJKE PHILIPS NVR- NY (PHG) is 2 / 10.


Is the dividend of KONINKLIJKE PHILIPS NVR- NY sustainable?

The dividend rating of KONINKLIJKE PHILIPS NVR- NY (PHG) is 6 / 10 and the dividend payout ratio is 36.65%.